Loading...
Chemical structure of Navocaftor

GC63479

Navocaftor

Also known as [5-[3-amino-5-[4-(trifluoromethoxy)phenyl]sulfonyl-2-pyridinyl]-1,3,4-oxadiazol-2-yl]methanol

Navocaftor (GLPG 3067), as a cystic fibrosis transmembrane regulator (CFTR), is a protein modulator (US 20200377491 Al, example 1)

ChemicalCAS2159103-66-7MW416.33FormulaC15H11F3N4O5S
CAS number
2159103-66-7
Molecular weight
416.33
Formula
C15H11F3N4O5S
Solubility
DMSO ： < 1 mg/mL (insoluble or slightly soluble)
InChIKey
WOXOLLSAICIZNO-UHFFFAOYSA-N
Catalogue number
GC63479
Brand
GLPBIO
Computed properties PubChem CID 132189640 · XLogP 0.8 · TPSA 150 Ų · H-bond donors 2
XLogP
0.8
TPSA
150 Ų
H-bond donors
2
H-bond acceptors
12
Rotatable bonds
5
Heavy atoms
28

SMILES C1=CC(=CC=C1OC(F)(F)F)S(=O)(=O)C2=CC(=C(N=C2)C3=NN=C(O3)CO)N

Computed descriptors from PubChem (CID 132189640), public domain. Identity cross-checked against the supplier's molecular formula and weight — verify before use.

Ordering in Israel

Lead time
Ships from the manufacturer to your lab in 8–14 business days; customs and cold chain handled by LABO Scientific.
Pricing
Quoted in ILS, excl. VAT. Add the item to your quote and we confirm the final price, usually the same business day.
Documents
Lot certificate of analysis and manufacturer SDS are emailed with your order confirmation.
Who we serve
Universities, hospitals and biotech companies across Israel. Research use only — not for diagnostic or therapeutic use.